Macquarie Group LTD Third Harmonic Bio, Inc. Transaction History

Macquarie Group LTD

$86.4 Billion
Q4 2024

A detailed history of Macquarie Group LTD transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 4,040 shares of THRD stock, worth $14,220. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,040

Holding current value

$14,220

% of portfolio

0.0%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 14, 2025	BUY	$10.29 - $15.4 $41,571 - $62,216	4,040 New	4,040 $41,000

Others Institutions Holding THRD

# of Institutions

Shares Held

40.2M

Call Options Held

100

Put Options Held

Atlas Venture Life Science Advisors, LLC

10.4M
Shares

$36.6 Million
17.65% of portfolio
Orbimed Advisors LLC San Diego, CA

5.78M
Shares

$20.3 Million
1.61% of portfolio
General Atlantic LLC New York, NY

3.37M
Shares

$11.9 Million
1.24% of portfolio
Eco R1 Capital, LLC San Francisco, CA

3.18M
Shares

$11.2 Million
1.53% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

2.93M
Shares

$10.3 Million
0.02% of portfolio

View Full List

About Third Harmonic Bio, Inc.

Ticker THRD
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,328,900
Market Cap $142M

More about THRD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account